# Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis

> **NCT04333875** · — · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 71 (actual)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DEVICE:** TAVR or SAVR

## Key facts

- **NCT ID:** NCT04333875
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-20
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2023-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04333875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04333875, "Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04333875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*